Stocktoria
Ceribell, Inc. CBLL
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2024-10-11
Chart by TradingView
3/9
Piotroski F — financial health
3.97
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $89.1M | $65.4M | $45.2M |
| Gross profit | $78.3M | $56.8M | $38.2M |
| Operating income | -$58.4M | -$39.7M | -$30.0M |
| Net income | -$53.4M | -$40.5M | -$29.5M |
| Operating cash flow | -$40.8M | -$35.0M | -$29.2M |
| Free cash flow | -$41.6M | -$36.4M | -$30.1M |
| Total assets | $195.8M | $225.4M | $58.9M |
| Total liabilities | $40.5M | $34.2M | $23.8M |
| Shareholders' equity | $155.3M | $191.2M | -$112.3M |
| Ratios | |||
| Gross margin | 87.9% | 86.7% | 84.4% |
| Operating margin | -65.6% | -60.7% | -66.4% |
| Net margin | -60.0% | -61.8% | -65.1% |
| FCF margin | -46.7% | -55.6% | -66.6% |
| Return on assets | -27.3% | -17.9% | -50.0% |
| Return on equity | -34.4% | -21.2% | 26.2% |
| Current ratio | 9.73 | 16.73 | 2.41 |
| Revenue growth | 36.1% | 44.7% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 77,733 | $1.4M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.97 (safe)
- Working capital / assets 0.856
- Retained earnings / assets -1.125
- EBIT / assets -0.298
- Equity / liabilities 3.839
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001861107 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.